Clinical drug development company Emyria Ltd has announced the beginning of phase 2B recruitment of patients for an MDMA-assisted clinical PTSD trial after Australia recently rescheduled the drug.
CSR [ASX:CSR] Acquires Woven Image in $43 Million Deal
CSR announced they have entered into an agreement to acquire long-term customer Woven Image for $43 million. The deal will broaden CSR’s range to include acoustic-focused products for commercial environments.
Australian Vintage [ASX:AVG] Shares Jump 10% as It Undertakes Strategic Review
Australian Vintage shares jump 10% as the company announces a strategic review to unlock shareholder value. The review will be run by the corporate advisory firm E&P.
Malteries Soufflet Buys United Malt [ASX:UMG] at $5 a Share
United Malt shares jump 8.98% this afternoon after announcing Malteries Soufflet signed a deal to buy out the craft beer and distillery producer for $5 per share. The deal still needs sign-off but could be a big move for malt producers worldwide.
Downer [ASX:DOW] Secures Contract for Queensland Train Manufacturing Worth $4.6 Billion
Integrated services giant Downer Edi announced today that it had secured a $4.6 billion contract with the QLD Government to build and maintain 65 new trains for Brisbane. The announcement saw Downers shares rise by 2.41%, trading at $4.035 per share.
Medibank [ASX:MPL] Faces $250 Million Penalty for Data Breach
Medibank faces a $250 million capital reserve requirement as punishment by the APRA for last October’s massive data breach in which the data of 9.7 million customers was stolen. Shares have remained resilient to the news, up by 1.71%, trading at $3.56 per share.
